Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas

Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
Conditions:   Gastric Adenocarcinoma;   Esophageal Adenocarcinoma;   Metastasis;   HER-2 Gene Amplification
Interventions:   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: 5 fluorouracil;   Drug: Trastuzumab;   Drug: Avelumab
Sponsors:   Michael Sangmin Lee;   EMD Serono;   University of North Carolina, Chapel Hill
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 16, 2019 / by / in
Comments